Home LiteratureArticle Details
PMID: 17673689 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.

American journal of respiratory cell and molecular biology ·Vol. 38 ·No. 1 ·2008-01-00 ·Pages 95-104

Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ

Abstract

Epithelial-to-mesenchymal transition (EMT) is a fundamental biological process whereby epithelial cells lose their polarity and undergo a transition to a mesenchymal phenotype. When cancer cells invade adjacent tissues, they use a mechanism akin to EMT, and understanding the molecular mechanisms that drive this transition will facilitate studies into new targets for prevention of metastasis. Extracellular stimuli, such as growth factors, and their cytosolic effectors cooperate to promote EMT. In highly fibrotic cancers like lung cancer, it is thought that extracellular matrix molecules, including collagen, can initiate signals that promote EMT. Here, we present data showing that collagen I induces EMT in non-small cell lung cancer cell lines, which is prevented by blocking transforming growth factor (TGF)-beta3 signaling. In addition, we show that collagen I-induced EMT is prevented by inhibitors of phosphoinositide 3-kinase and extracellular signal-related kinase signaling, which promotes transcription of TGF-beta3 mRNA in these cells. Thus, our data are consistent with the hypothesis that collagen I induces EMT in lung cancer cells by activating autocrine TGF-beta3 signaling. Epidermal growth factor also seems to initiate EMT via a TGF-dependent mechanism.

MeSH Terms
Animals Autocrine Communication/drug effects Carcinoma, Non-Small-Cell Lung/metabolism,pathology Cell Line, Tumor Cell Polarity/drug effects Collagen Type I/metabolism,pharmacology Epidermal Growth Factor/metabolism Epithelial Cells/metabolism,pathology Humans Lung Neoplasms/metabolism,pathology MAP Kinase Signaling System/drug effects Mice Neoplasm Metastasis Neoplasm Proteins/biosynthesis Phosphatidylinositol 3-Kinases RNA, Messenger/biosynthesis RNA, Neoplasm/biosynthesis Transforming Growth Factor beta3/biosynthesis
Chemicals
Collagen Type I Neoplasm Proteins RNA, Messenger RNA, Neoplasm Transforming Growth Factor beta3 Epidermal Growth Factor Phosphatidylinositol 3-Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Shintani Yasushi
Department of Oral Biology, Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Maeda Masato
Chaika Nina
Johnson Keith R
Wheelock Margaret J
References (50)
50 references, click to expand
  1. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.
    J Cell Biol. 1999 Nov 1;147(3):631-44 PMID: 10545506
  2. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.
    J Cell Sci. 2006 Sep 15;119(Pt 18):3856-65 PMID: 16940349
  3. Retinoic acid down-regulates VPAC(1) receptors and TGF-beta 3 but up-regulates TGF-beta 2 in lung cancer cells.
    Peptides. 2000 Dec;21(12):1831-7 PMID: 11150643
  4. How cells read TGF-beta signals.
    Nat Rev Mol Cell Biol. 2000 Dec;1(3):169-78 PMID: 11252892
  5. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer.
    Ann Thorac Surg. 2001 Mar;71(3):949-54; discussion 954-5 PMID: 11269479
  6. TGF-beta signaling in cancer--a double-edged sword.
    Trends Cell Biol. 2001 Nov;11(11):S44-51 PMID: 11684442
  7. Lung cancer--time to move on from chemotherapy.
    N Engl J Med. 2002 Jan 10;346(2):126-8 PMID: 11784881
  8. Growth factors in idiopathic pulmonary fibrosis: relative roles.
    Respir Res. 2002;3:13 PMID: 11806848
  9. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.
    J Clin Oncol. 2002 May 15;20(10):2417-28 PMID: 12011119
  10. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Virchows Arch. 2002 May;440(5):491-7 PMID: 12021923
  11. Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism.
    J Lab Clin Med. 2002 Nov;140(5):342-50 PMID: 12434136
  12. Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.
    Cancer Res. 2002 Dec 15;62(24):7135-8 PMID: 12499244
  13. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
    J Clin Oncol. 2003 Jun 15;21(12):2237-46 PMID: 12748244
  14. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.
    Nat Rev Mol Cell Biol. 2003 Aug;4(8):657-65 PMID: 12923528
  15. Cadherins as modulators of cellular phenotype.
    Annu Rev Cell Dev Biol. 2003;19:207-35 PMID: 14570569
  16. Epithelial-mesenchymal transitions in development and pathologies.
    Curr Opin Cell Biol. 2003 Dec;15(6):740-6 PMID: 14644200
  17. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.
    Cancer Cell. 2003 Dec;4(6):499-515 PMID: 14706341
  18. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis.
    Mutat Res. 2004 Jan;566(1):9-20 PMID: 14706509
  19. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
    Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13180-5 PMID: 16924102
  20. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion.
    J Cell Biol. 1996 Dec;135(6 Pt 1):1643-54 PMID: 8978829
  21. Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells.
    Respir Res. 2006;7:114 PMID: 16948840
  22. Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.
    J Clin Oncol. 2006 Oct 10;24(29):4721-30 PMID: 16966690
  23. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma.
    Cell Adhes Commun. 1997 Mar;4(6):399-411 PMID: 9177902
  24. Epitope tag-antibody combination useful for the detection of protein expression in prokaryotic and eukaryotic cells.
    Biotechniques. 1997 Jul;23(1):96-7 PMID: 9232237
  25. Cyclosporine induces cancer progression by a cell-autonomous mechanism.
    Nature. 1999 Feb 11;397(6719):530-4 PMID: 10028970
  26. Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3.
    Am J Physiol. 1999 May;276(5 Pt 1):G1087-93 PMID: 10329998
  27. Friends or foes - bipolar effects of the tumour stroma in cancer.
    Nat Rev Cancer. 2004 Nov;4(11):839-49 PMID: 15516957
  28. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma.
    Br J Cancer. 2005 Jan 31;92(2):252-8 PMID: 15668718
  29. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.
    J Cell Sci. 2005 Mar 1;118(Pt 5):873-87 PMID: 15713751
  30. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?
    Cancer Res. 2005 Jul 15;65(14):5991-5; discussion 5995 PMID: 16024595
  31. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Respir Res. 2005;6:56 PMID: 15946381
  32. TGF-beta and epithelial-to-mesenchymal transitions.
    Oncogene. 2005 Aug 29;24(37):5764-74 PMID: 16123809
  33. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.
    Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8686-98 PMID: 16361555
  34. Expression of transforming growth factor beta1, beta2, and beta3 in chronic, cancer-associated, obstructive pancreatitis.
    Arch Pathol Lab Med. 2006 Mar;130(3):356-61 PMID: 16519564
  35. The epithelial-mesenchymal transition: new insights in signaling, development, and disease.
    J Cell Biol. 2006 Mar 27;172(7):973-81 PMID: 16567498
  36. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells.
    Cancer Res. 2006 May 1;66(9):4662-71 PMID: 16651417
  37. Phosphoinositide-3 kinase-Rac1-c-Jun NH2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells.
    Mol Biol Cell. 2006 Jul;17(7):2963-75 PMID: 16624865
  38. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
    Carcinogenesis. 2006 Nov;27(11):2170-9 PMID: 16632868
  39. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression.
    Cancer Res. 2006 Dec 15;66(24):11745-53 PMID: 17178870
  40. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs.
    Clin Cancer Res. 2006 Dec 15;12(24):7242-51 PMID: 17189395
  41. Transforming growth factor-beta3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of X-linked inhibitor of apoptosis and protein kinase c-dependent induction of matrix metalloproteinase-9.
    J Biol Chem. 2007 Feb 16;282(7):4794-802 PMID: 17150964
  42. SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells.
    Cell Signal. 2007 May;19(5):923-31 PMID: 17197157
  43. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
    Oncogene. 2007 Apr 19;26(18):2658-66 PMID: 17057737
  44. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
    Science. 2007 May 18;316(5827):1039-43 PMID: 17463250
  45. Multidisciplinary management of lung cancer.
    N Engl J Med. 2004 Jan 22;350(4):379-92 PMID: 14736930
  46. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
    Cell. 2004 Jun 25;117(7):927-39 PMID: 15210113
  47. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
    J Immunol. 1989 Nov 15;143(10):3222-9 PMID: 2809198
  48. Cadherin cell adhesion receptors as a morphogenetic regulator.
    Science. 1991 Mar 22;251(5000):1451-5 PMID: 2006419
  49. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.
    J Cell Sci. 1995 Mar;108 ( Pt 3):985-1002 PMID: 7542672
  50. Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma.
    Cancer. 1999 Nov 1;86(9):1712-9 PMID: 10547543
Article Info
Journal
American journal of respiratory cell and molecular biology
Abbr.
Am J Respir Cell Mol Biol
ISSN
1535-4989
Published
2008-01-00
Epub
2007-00-02
Pages
95-104
Language
English
Region
United States
NLM ID
8917225
PMCID
PMC2176131
Subset
IM
Grants
NCI NIH HHS · P30 CA36727 · United States
NIDCR NIH HHS · R01-DE12308 · United States
NIGMS NIH HHS · R01-GM51188 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com